国际肿瘤学杂志››2014,Vol. 41››Issue (7): 503-507.doi:10.3760/cma.j.issn.1673422X.2014.07.007

• 综述 •上一篇下一篇

核因子κB与肿瘤放射治疗

杜正云,肖宝荣,翟西菊

    • 出版日期:2014-08-04发布日期:2014-08-04
    • 通讯作者:肖宝荣,Email:merry21@163.com E-mail:merry21@163.com

    NFκB in neoplasms radiotherapy

    DU Zheng-Yun, XIAO Bao-Rong, DI Xi-Ju

      • Online:2014-08-04Published:2014-08-04
      • Contact:Xiao Baorong E-mail:merry21@163.com

      摘要:核因子κB(NFκB)是哺乳动物真核细胞中重要的转录因子,在机体免疫、炎症以及肿瘤的发生发展、浸润转移、肿瘤细胞凋亡方面起着重要作用。近年来研究发现,NFκB在肿瘤中高表达与肿瘤耐放射治疗及预后差密切相关,NFκB可作为评价放疗疗效及预后的指标。针对NFκB激活的通路,可以从不同的方面寻找药物抑制NFκB的激活,提高放疗疗效。

      关键词:NF&kappa,B,肿瘤,放射疗法

      Abstract:Nuclear factor κB (NFκB) is an important transcription factor in mammalian cells. As a multifunctional factor, NFκB is involved in a variety of physiological and pathological processes such as immunity and inflammation . At the molecular and cellular level, NFκB regulates initiation and progression of neoplasms. NFκB also plays an important role in cell proliferation and apoptosis of neoplasms. Radiotherapy is one of the most important methods in tumor treatment .In recent years, a number of studies discovered that NFκB is critical in the development of resistance of tumor cells to radiotherapy, which results in poor prognosis. We can use NFκB as a biomarker in predicting outcomes of anticancer treatment or as prognostic indicators in patients who are with tumors. So we can find different potential inhibitors aimed at NFκB and its signal pathway in order to improve the efficacy of radiotherapy. In the present study, the correlation of NFκB molecules with radiotherapy of neoplasms is reviewed.

      Key words:NFkappa B,Neoplasms,Radiotherapy